Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Markets Trade in the Red
Wed, 2 Dec 01:30 pm

After opening flat, the Indian Indices slipped into the red during the post noon trading session. Sectoral indices are trading on a mixed note with stocks from the capital goods, IT and banking sectors bearing the maximum brunt.

The BSE-Sensex is trading lower by 94 (down 0.4%) and the NSE-Nifty is trading down by 36 points (down 0.5%). The S&P BSE Midcap and the S&P BSE Smallcap indices are also trading in the red, both down by 0.1%. Gold prices, per 10 grams, are trading at Rs 25,077 levels. Silver price, per kilogram, is trading at Rs 33,553 levels. Crude oil is trading at Rs 2,781 per barrel. The rupee is trading at 66.56 to the US$.

Stock in the automobile space are trading on a mixed note with Maruti Suzuki and Tube Investments leading the gains. India's largest two-wheeler maker Hero MotoCorp has reported a marginal increase in its sales for the month of November.

The company has sold 5,50,731 units during the period, a 0.6% increase over the same period last year. The company stated that it has achieved the landmark of one million unit sales during the 35-day festive period starting with the Navratras, recording a 11% YoY growth.

Most of the performance was boosted by demand for new scooters Maestro Edge and Duet. Also, the new motorcycle launches namely Splendor PRO, along with Passion PRO and Glamour, have aided the sales growth.

Hero MotoCorp is the world's single largest two-wheeler motorcycle company. It is engaged in the manufacture of two wheelers, motorcycles and its parts. The company has recently announced its second quarter results for the financial year 2015-2106 (2QFY16). It reported a 1.1% YoY fall in sales, while net profits rose by 1.1% YoY. If you are interested in the stock, here is our detailed analysis of the results (subscription required).

Presently the stock of Hero MotoCorp is trading up by 0.2%.

Pharma stocks are also trading mixed with Dishman Pharma and Natco Pharma leading the losses. As per an article in Economic Times, the government's decision to reduce prices of drugs has benefitted the public to the tune of nearly Rs 27.7 billion. The development relates to the inclusion of all the NLEM (national list of essential medicines) in the first schedule of DPCO, 2013, for bringing prices under control.

Out of a total of 680 medicines under the NLEM, the National Pharmaceutical pricing Authority (NPPA) has already fixed the ceiling prices in respect of 530 medicines. This includes 47 formulations for cancer, 53 for cardiovascular diseases, 20 for AIDS/HIV and 6 for diabetes. Moreover, maximum retail price has been capped in respect of 106 non-scheduled medicines, under para 19, of the Drug Price Control Order (DPCO) 2013.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian Markets Trade in the Red". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.